These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8799250)

  • 1. Quantification of technetium 99m-labeled sestamibi single-photon emission computed tomography based on mean counts improves accuracy for assessment of relative regional myocardial blood flow: experimental validation in a canine model.
    Liu YH; Sinusas AJ; Shi CQ; Shen MY; Dione DP; Heller EN; Wackers FJ
    J Nucl Cardiol; 1996; 3(4):312-20. PubMed ID: 8799250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction.
    De Coster PM; Wijns W; Cauwe F; Robert A; Beckers C; Melin JA
    Circulation; 1990 Dec; 82(6):2152-62. PubMed ID: 2242539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of single-photon emission computed tomographic (SPECT) myocardial perfusion imaging with thallium-201 and technetium-99m sestamibi in dogs.
    Leon AR; Eisner RL; Martin SE; Schmarkey LS; Aaron AM; Boyers AS; Burnham KM; Oh DJ; Patterson RE
    J Am Coll Cardiol; 1992 Dec; 20(7):1612-25. PubMed ID: 1452936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging.
    Wu JC; Yun JJ; Heller EN; Dione DP; DeMan P; Liu YH; Zaret BL; Wackers FJ; Sinusas AJ
    J Nucl Med; 1998 Mar; 39(3):417-25. PubMed ID: 9529285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201.
    Sinusas AJ; Watson DD; Cannon JM; Beller GA
    J Am Coll Cardiol; 1989 Dec; 14(7):1785-93. PubMed ID: 2584570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental verification of technetium 99m-labeled teboroxime kinetic parameters in the myocardium with dynamic single-photon emission computed tomography: reproducibility, correlation to flow, and susceptibility to extravascular contamination.
    Smith AM; Gullberg GT; Christian PE
    J Nucl Cardiol; 1996; 3(2):130-42. PubMed ID: 8799238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of collateral flow and myocardial viability on the distribution of technetium-99m sestamibi in a closed-chest model of coronary occlusion and reperfusion.
    Chareonthaitawee P; O'Connor MK; Gibbons RJ; Ritman EL; Christian TF
    Eur J Nucl Med; 2000 May; 27(5):508-16. PubMed ID: 10853805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile.
    Sinusas AJ; Trautman KA; Bergin JD; Watson DD; Ruiz M; Smith WH; Beller GA
    Circulation; 1990 Oct; 82(4):1424-37. PubMed ID: 2401074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of patient height and weight and type of stress on myocardial count density during SPECT imaging with thallium-201 and technetium 99m-sestamibi.
    O'Connor MK; Bothun E; Gibbons RJ
    J Nucl Cardiol; 1998; 5(3):304-12. PubMed ID: 9669585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
    De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
    Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.
    Miller DD; Donohue TJ; Younis LT; Bach RG; Aguirre FV; Wittry MD; Goodgold HM; Chaitman BR; Kern MJ
    Circulation; 1994 May; 89(5):2150-60. PubMed ID: 8181140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
    Liu M; Ma Z; Guo X; Zhu J; Su J
    Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPECT myocardial blood flow quantitation toward clinical use: a comparative study with
    Hsu B; Hu LH; Yang BH; Chen LC; Chen YK; Ting CH; Hung GU; Huang WS; Wu TC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):117-128. PubMed ID: 27585576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between myocardial uptake of technetium-99m-sestamibi and pressure-derived myocardial fractional flow reserve.
    Morishima T; Chikamori T; Hatano T; Tanaka N; Takazawa K; Yamashina A
    J Cardiol; 2004 Apr; 43(4):155-63. PubMed ID: 15125379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis.
    Sinusas AJ; Bergin JD; Edwards NC; Watson DD; Ruiz M; Makuch RW; Smith WH; Beller GA
    Circulation; 1994 May; 89(5):2332-41. PubMed ID: 8181159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of regional ventricular function, geometry, and dobutamine stress on quantitative 99mTc-sestamibi defect size.
    Sinusas AJ; Shi Q; Vitols PJ; Fetterman RC; Maniawski P; Zaret BL; Wackers FJ
    Circulation; 1993 Nov; 88(5 Pt 1):2224-34. PubMed ID: 8222117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
    Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
    J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of 99mTc-sestamibi SPECT myocardial perfusion imaging with absolute coronary flow reserve by a new noninvasive Doppler method in patients with stenoses of the left anterior descending coronary artery. A preliminary report.
    Caiati C; Cioglia G; Montaldo C; Zedda N; Rubini G; Pirisi R; Iliceto S
    Cardiologia; 1999 Sep; 44(9):809-16. PubMed ID: 10609390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arbutamine stress perfusion imaging in dogs with critical coronary artery stenoses: (99m)Tc-sestamibi versus (201)Tl.
    Ruiz M; Takehana K; Petruzella FD; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2002 May; 43(5):664-70. PubMed ID: 11994532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.